IQI
HALO icon

Integrated Quantitative Investments’s Halozyme HALO Stock Holding History

Integrated Quantitative Investments’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,127
Closed -$210K – 457
2025
Q4 		$210K Buy
+3,127
New +$210K 0.05% 380

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Integrated Quantitative Investments's HALO Position: Q1 2026 in Review

Integrated Quantitative Investments sold out of Halozyme (HALO) in Q1 2026, closing a stake of 3,127 shares — an estimated $210K sold.

Integrated Quantitative Investments first reported a position in HALO in Q4 2025 and held it in 1 quarter. The position peaked at $210K in Q4 2025. 637 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Integrated Quantitative Investments reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Integrated Quantitative Investments sold 3,127 Halozyme shares in Q1 2026, an estimated $210K.
  • Integrated Quantitative Investments first reported a position in Halozyme in Q4 2025 and held it in 1 quarter.
  • Integrated Quantitative Investments's Halozyme position peaked at $210K in Q4 2025.
  • 637 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Integrated Quantitative Investments's 13F filing for Q1 2026, filed 13 May 2026.